SHA:688076 Revenue

Jiangsu Sinopep-Allsino Biopharmaceutical had revenue of 565.60M CNY in the quarter ending March 31, 2025, with 58.96% growth. This brings the company's revenue in the last twelve months to 1.83B, up 55.29% year-over-year. In the year 2024, Jiangsu Sinopep-Allsino Biopharmaceutical had annual revenue of 1.62B with 57.21% growth.

Revenue (ttm)

1.83B

Revenue Growth

+55.29%

P/S Ratio

6.67

Revenue / Employee

1.19M

Employees

1,545

Market Cap

12.23B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.62B	591.25M	57.21%
Dec 31, 2023	1.03B	382.26M	58.69%
Dec 31, 2022	651.29M	7.42M	1.15%
Dec 31, 2021	643.87M	77.00M	13.58%
Dec 31, 2020	566.87M	195.34M	52.58%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings